Choose your country to see the products for your location
SALSA® MLPA® probemixes P081 NF1 mix 1 and P082 NF1 mix 2 detect copy number variations in the NF1 gene.
Contents: P081 NF1 mix 1 and P082 NF1 mix 2 together contain 90 MLPA probes, including 67 probes for NF1 (covering all 58 exons) and two probes for OMG.
Tissue: genomic DNA isolated from human peripheral whole blood.
Application: neurofibromatosis type 1 (NF1).
CE-marked and registered for in vitro diagnostic (IVD) use in selected territories.
The SALSA MLPA Probemixes P081 NF1 mix 1 and P082 NF1 mix 2 are in vitro diagnostic (IVD) or research use only (RUO) semi-quantitative assays for the detection of deletions or duplications in the NF1 gene in genomic DNA isolated from human peripheral whole blood specimens. P081 NF1 mix 1 and P082 NF1 mix 2 are intended to confirm a potential cause for and clinical diagnosis of Neurofibromatosis type 1 (NF1) and for molecular genetic testing of at-risk family members.
For the full intended purpose, see the product description.
Neurofibromatosis is an autosomal dominant disorder characterised particularly by café-au-lait spots and fibromatous tumours of the skin. Neurofibromatosis type 1 is caused by loss-of-function mutations in the NF1 gene on 17q11.2. Neurofibromatosis type 2 is caused by defects in the NF2 gene on chromosome 22q12.2, for which the SALSA MLPA Probemix P044 NF2 can be used.
Estimated birth incidence of Neurofibromatosis type 1 is 1 in 3000, with about half of the NF1 cases caused by de novo sporadic mutations. De novo sporadic mutations may also be the result of germline mosaicism in apparently unaffected parents. Partial deletions and duplications as well as deletions and duplications of the complete NF1 gene have been described. Relatively common (5-10% of NF1 cases) is a deletion of a 1.4 Mb chromosomal region harbouring multiple genes, including the NF1 gene. The phenotype of this 17q11.2 microdeletion is usually more severe than most other NF1 cases and may include developmental delay. Next to the 1.4 Mb deletion described above, a 1.2 Mb microdeletion and nonrecurrent atypical microdeletions of different sizes have been reported. The SALSA MLPA Probemix P122 NF1-area (RUO) can be used to determine the extent of the deletion as it contains many probes for other genes in the frequently deleted 1.4 Mb region. More information is available on https://www.ncbi.nlm.nih.gov/books/NBK1109/.
SALSA MLPA Probemix P082 NF1 mix 2 is CE-marked for in vitro diagnostic (IVD) use. This assay has also been registered for IVD use in Colombia and Israel.
This assay is for research use only (RUO) in all other territories.
A general SALSA MLPA Reagent Kit is required for MLPA experiments (to be ordered separately).
The prices above are list prices for direct orders from MRC Holland. Contact us for a quote that takes discounts and additional costs (such as shipping costs) into account. Different prices apply for orders through one of our sales partners; contact your local supplier for a quote.
Inclusion of a positive sample is usually not required, but can be useful for the analysis of your experiments. MRC Holland has very limited access to positive samples and cannot supply such samples. We recommend using positive samples from your own collection. Alternatively, you can use positive samples from an online biorepository, such as the Coriell Institute.
We have no information about specific commercially available positive samples that can be used with this product.